VBIV(Delisted)
VBI VaccinesยทNASDAQ
--
--(--)
VBIV Profile
Vbi Vaccines Inc.
A commercial stage biopharmaceutical company that developing vaccines for significant infectious diseases
160 Second Street, Floor 3, Cambridge, MA 02142
--
VBI Vaccines Inc. was incorporated on April 9, 1965 under the laws of British Columbia. The company is an immunology-driven commercial-stage biopharmaceutical company pursuing the prevention and treatment of diseases. Through its innovative approach to virus-like particles, including proprietary coated VLP platform technology and proprietary mRNA-launched eVLP platform technology, VBI develops candidate vaccines that mimic the natural presentation of viruses and are designed to stimulate the innate power of the human immune system. VBI is dedicated to targeting and overcoming major infectious diseases, including hepatitis B, new Covid-19 and coronavirus, cytomegalovirus, and aggressive cancers including glioblastoma.
